October 16, 2026Stocks·Bullish·regulatory
EMA's CHMP recommends indication extension for Ionis' TRYNGOLZA in severe hypertriglyceridemia
Ionis Pharmaceuticals received a positive opinion from the EMA's CHMP recommending an indication extension for TRYNGOLZA for the treatment of adult patients with severe hypertriglyceridemia.
Detected & updated continuously · Source: Nebula
Story subjects